Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

Technology Scientific & Technical Instruments
MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

MedMira Inc > 36 + 11 = 47 MILLION SHARES IS NOT TEMPORARY ETHEGREAT
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(6871)
•••
Comment by EtheGreaton Dec 15, 2021 5:43pm
120 Views
Post# 34234713

RE:36 + 11 = 47 MILLION SHARES IS NOT TEMPORARY ETHEGREAT

RE:36 + 11 = 47 MILLION SHARES IS NOT TEMPORARY ETHEGREAT'august202013' All Points Acknowledged & Well Taken ! IMO the Deal keeps 'Mother MIR' Afloat & Proceeding to Next Step = PROFITs ! The Good, The Bad, The Ugly ! Ain't Seen a Perfect World Yet... Prefer to Let's Move Out of Current Stuck in the Muck Position to Profitability , then Revisit Details Later... EthrGreat or Not ?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities